logo-loader
viewLloyds Banking Group

Lloyds to cut CEO’s salary by £228,000 following backlash over executive pay

The FTSE 100 lender will also be pumping in £20mln to help boost the salaries of its other 65,000 staff

Lloyds Banking Group - Lloyds to cut CEO’s salary by £228,000 following backlash over executive pay
Despite the change, Antonio Horta-Osorio will still receive at least £2.8mln this year

The chief executive of Lloyds Banking Group PLC (LON:LLOY), Antonio Horta-Osorio, is to have his salary cut by around £228,000 as the banking giant aims to respond to criticism of its executive pension policy.

The FTSE 100 will also be pumping in £20mln to help boost the salaries of its 65,000 staff.

READ: StanChart halves top executives’ pension after shareholders protest

Currently, Lloyds provides its chief executive with a pension allowance equal to around 33% of his pay packet, much higher than the average 13% contribution for the rest of its employees.

However, the bank has since told shareholders that from next year it will increase the allowance for its staff to 15% of their base pay, according to sources quoted in the Financial Times.

The change will result in the aforementioned reduction in Horta-Osorio’s salary, although he is still guaranteed at least £2.8mln this year, plus bonuses.

Lloyds’ move to cut back the salary of its boss follows criticism earlier this year around executive pay in the industry.

Earlier this month, fellow blue-chip bank Standard Chartered PLC (LON:STAN) said it would halve the pension allowance for its chief executive and chief financial officer following protests from shareholders, bringing its policy in line with industry standards.

In late-morning trading on Wednesday, Lloyd’s shares were 0.4% higher at 61.5p.

Quick facts: Lloyds Banking Group

Price: - -

LSE:LLOY
Market: LSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 1 hour ago

2 min read